Metal Nanoparticles
in Pharma
in Pharma
Drug Delivery Aspects
Expectations and Realities of
Multifunctional Drug Delivery Systems
Expectations and Realities of
Multifunctional Drug Delivery Systems
Delivery of Drugs
Expectations and Realities of
Multifunctional Drug Delivery Systems
Expectations and Realities of
Multifunctional Drug Delivery Systems
Delivery of Drugs
Expectations and Realities of
Multifunctional Drug Delivery Systems
Expectations and Realities of
Multifunctional Drug Delivery Systems
Delivery of Drugs
Expectations and Realities of
Multifunctional Drug Delivery Systems
Expectations and Realities of
Multifunctional Drug Delivery Systems
Delivery of Drugs
Expectations and Realities of
Multifunctional Drug Delivery Systems
Expectations and Realities of
Multifunctional Drug Delivery Systems
Ranjita Shegokar Ph.D
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. For the last many years she has been working with various multinational pharmaceutical companies in technical/R&D leadership roles. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems.
Ranjita Shegokar Ph.D
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University,
India, and has been a postdoctoral researcher in the Department of Pharmaceutics,
Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany.
For the last many years she has been working with various multinational pharmaceutical companies in technical/R&D leadership roles.
Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany.
She has authored several research articles, book chapters, and presented her research in many national/international conferences.
She has filed multiple patent applications in the area of drug delivery and targeting.
Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects.
For her research, she has received many prestigious national and international awards among them include recently
received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs),
nanoemulsions, cancer drug targeting and the role of excipients in delivery systems.
| Master's – Pharm Tech | Immediate release pediatric suppositories | Post-Doc. – Pharm Nanotech | Dermal and mucosal drug targeting : Nanoparticles | DFE Pharma GmbH & Co. KG | Oral Solid Dosage Forms (OSDFs) | Capnomed GmbH | Drug Targeting – conventional/nano/micro | ||||
| PhD – Pharm Nanotech | Drug Targeting to splenic HIV reservoirs : Nanoparticle | PharmaSol GmbH | Nanocrystals- industrial production | Symrise AG | Immediate and controlled active release (Conventional/nano/micro) | ||||||
| Master's – Pharm Tech | Immediate release pediatric suppositories | PhD – Pharm Nanotech | Drug Targeting to splenic HIV reservoirs : Nanoparticle | Post-Doc. – Pharm Nanotech | Dermal and mucosal drug targeting : Nanoparticles | PharmaSol GmbH | Nanocrystals- industrial production | DFE Pharma GmbH & Co. KG | Oral Solid Dosage Forms (OSDFs) | Symrise AG | Immediate and controlled active release (Conventional/nano/micro) | Capnomed GmbH | Drug Targeting – conventional/nano/micro | |||||||
Middle-chain triglyceride mixed with glyceryl tripalmitate or with carnauba wax, carnauba wax... Read more
Quercetin nanocrystals were successfully fabricated by means of three methods, namely... Read more
This article successfully reviews practical considerations to manufacture nano-crystalline... Read more
Poor solubility of new drugs and their related low oral bioavailability and general delivery... Read more
The development and characterization of lipid nanoparticle of stavudine with robust particle size... Read more
The challenges in treating AIDS, malaria, tuberculosis, chagas and others can be reduced to... Read more